Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.780
+0.030 (0.80%)
At close: Sep 18, 2026, 4:00 PM EDT
3.765
-0.015 (-0.40%)
After-hours: Sep 18, 2026, 6:58 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $875.21 million as of September 18, 2026. Its market cap has increased by 20.46% in one year.
Market Cap
875.21M
Enterprise Value
1.03B
1-Year Change
20.46%
Ranking
Category
Stock Price
$3.78
ChartMarket Cap Chart
Since July 10, 2020, Inventiva's market cap has increased from $547.96M to $875.21M, an increase of 59.72%. That is a compound annual growth rate of 7.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 899.28M | 1.63% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 1.01B |
| Arbutus Biopharma | 1.00B |
| SpyGlass Pharma | 968.65M |
| Adlai Nortye Group | 965.97M |
| Cybin | 958.55M |
| Sana Biotechnology | 945.98M |
| Faeth Therapeutics | 913.98M |
| Solid Biosciences | 897.48M |